ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.4953
-0.68%
Brent Oil
83.76
0.00%
Bitcoin
66,023.97
-1.37%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Infinity Pharmaceuticals Inc (INFI)

  7. Infinity Pharmaceuticals Inc (INFI) Noticias

INFI

Infinity Pharmaceuticals (INFI)

Infinity Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:INFI
FechaHoraFuenteTítuloSímboloCompañía
13/09/202307:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INFIInfinity Pharmaceuticals Inc
12/09/202317:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INFIInfinity Pharmaceuticals Inc
10/08/202315:32Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INFIInfinity Pharmaceuticals Inc
25/07/202315:05Business WireInfinity Pharmaceuticals Announces Value Preservation and Maximization PlanNASDAQ:INFIInfinity Pharmaceuticals Inc
24/07/202307:30Business WireInfinity Pharmaceuticals Announces Termination of Merger Agreement with MEI PharmaNASDAQ:INFIInfinity Pharmaceuticals Inc
14/07/202312:00Business WireInfinity Pharmaceuticals Announces Stockholder Approval of Merger with MEI PharmaNASDAQ:INFIInfinity Pharmaceuticals Inc
10/07/202307:30Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INFIInfinity Pharmaceuticals Inc
10/07/202307:30Business WireInfinity Pharmaceuticals Provides Additional Information on MARIO-8 Study Evaluating Eganelisib in Combination with the PD-1 Targeted Checkpoint Inhibitor Pembrolizumab (KEYTRUDA®) in Patients with Squamous Cell Cancer of the Head and Neck (SCCHN)NASDAQ:INFIInfinity Pharmaceuticals Inc
05/07/202307:30Business WireISS Recommends Infinity Pharmaceuticals Stockholders Vote FOR the Merger with MEI Pharma, Inc.NASDAQ:INFIInfinity Pharmaceuticals Inc
03/07/202315:57Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:INFIInfinity Pharmaceuticals Inc
27/06/202307:31Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INFIInfinity Pharmaceuticals Inc
20/06/202307:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INFIInfinity Pharmaceuticals Inc
15/06/202311:08Business WireMEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology CandidatesNASDAQ:INFIInfinity Pharmaceuticals Inc
13/04/202315:05Business WireInfinity Pharmaceuticals Announces Two Upcoming Presentations on PI3K-γ and Eganelisib by Dr. Judith Varner at the 2023 Annual Meeting of the American Association of Cancer ResearchNASDAQ:INFIInfinity Pharmaceuticals Inc
28/03/202315:05Business WireInfinity Pharmaceuticals Reports Full Year 2022 Financial ResultsNASDAQ:INFIInfinity Pharmaceuticals Inc
28/03/202314:58Edgar (US Regulatory)Annual Report (10-k)NASDAQ:INFIInfinity Pharmaceuticals Inc
23/02/202316:32Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:INFIInfinity Pharmaceuticals Inc
23/02/202312:19PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Infinity Pharmaceuticals, Inc.NASDAQ:INFIInfinity Pharmaceuticals Inc
23/02/202306:00Business WireMEI Pharma and Infinity Pharmaceuticals Announce Definitive Merger Agreement to Advance Three Promising Clinical Oncology CandidatesNASDAQ:INFIInfinity Pharmaceuticals Inc
09/02/202310:36Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:INFIInfinity Pharmaceuticals Inc
22/11/202207:35Business WireInfinity Pharmaceuticals to Participate in Piper Sandler 34th Annual Healthcare ConferenceNASDAQ:INFIInfinity Pharmaceuticals Inc
14/11/202211:40TipRanksAnalysts Offer Insights on Healthcare Companies: Gamida Cell (GMDA) and Infinity Pharma (INFI)NASDAQ:INFIInfinity Pharmaceuticals Inc
14/11/202206:07Business WireInfinity Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business UpdateNASDAQ:INFIInfinity Pharmaceuticals Inc
14/11/202206:05Business WireInfinity Pharmaceuticals Provides MARIO-3 Update in Patients with Front Line Metastatic Triple Negative Breast Cancer Suggesting Potential Long-Term Patient Benefit of EganelisibNASDAQ:INFIInfinity Pharmaceuticals Inc
07/11/202207:25Business WireInfinity Pharmaceuticals Announces the Date of Its Third Quarter 2022 Financial Results Conference Call and WebcastNASDAQ:INFIInfinity Pharmaceuticals Inc
31/08/202206:00Business WireInfinity to Participate in Wells Fargo and H.C. Wainwright Investor ConferencesNASDAQ:INFIInfinity Pharmaceuticals Inc
12/08/202214:05TipRanksJonesTrading Reaffirms Their Hold Rating on Infinity Pharma (INFI)NASDAQ:INFIInfinity Pharmaceuticals Inc
09/08/202215:05Business WireInfinity Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business UpdateNASDAQ:INFIInfinity Pharmaceuticals Inc
09/08/202214:52Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:INFIInfinity Pharmaceuticals Inc
04/08/202217:28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INFIInfinity Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:INFI

Su Consulta Reciente

NASDAQ
DWID
EU
Y619S
Y619S
COIN
TKAEUR
CSE
LLP
LeanLife Health
LATK
JCHUSDT
JobCash
POLO
ADABEARUSDT
3X Short Cardano Token
TSXV
NU
NeutriSci
USOTC
RCVHS
RSE Archive (GM)
USOTC
GRCU
Green Cures and Botanica... (PK)
AQSE
ADB
Adnams
LSE
AO53
Citi Fun 24
NASDAQ
AINN
Applied Innovation
USOTC
AILIM
Ameren Illinois (PK)
NYSE
RXY
KUCN
SFUNDUSDT
SeedifyFund
KOSPI
004415
Seoul Food Ind
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados